Healthcare -
Biotechnology - NASDAQ - US
$ 23.46
-0.509 %
$ 3.38 B
Market Cap
-8.5
P/E
DNLI - RESEARCH & DEVELOPMENT
Research & Development DNLI - Denali Therapeutics Inc.
424 M
LAST VALUE
26.39%
2 YEAR CAGR
24.24%
5 YEAR CAGR
0.00%
10 YEAR CAGR